ArticleCancer medicine2020

Efficacy and safety of low-dose apatinib in ovarian cancer patients with platinum-resistance or platinum-refractoriness: A single-center retrospective study.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.